bobbybobby
MarketsStocksJoin Us

SCHD: A Forever Holding for Passive Income

Jul 3, 2026
Bobby Quant Team

💡 Key Takeaway

SCHD offers a 3.25% dividend yield with low costs and consistent growth, making it a strong forever holding for passive income.

SCHD: A Dividend ETF for the Long Haul

The article discusses how investors seeking reliable passive income should consider the Schwab U.S. Dividend Equity ETF (SCHD) as a forever holding.

SCHD tracks the Dow Jones U.S. Dividend 100, selecting companies with at least 10 years of dividend payments and strong financial metrics like cash flow to debt, return on equity, and dividend growth.

The ETF boasts a 3.25% distribution yield, more than three times the S&P 500's 1.07%, and its payout has grown 211% over the past decade.

Top holdings include UnitedHealth Group (UNH), Merck (MRK), and Home Depot (HD), all established businesses with steady earnings.

In 2026, SCHD delivered an 18.9% total return, outperforming the S&P 500's 8.1%, providing a safe haven amid uncertainty.

Why SCHD Matters for Income Investors

SCHD's consistent dividend growth and low expense ratio (0.06%) make it an attractive vehicle for long-term income investors.

The ETF's focus on high-quality, dividend-paying stocks can provide stability during market volatility.

By outperforming the S&P 500 year-to-date, SCHD demonstrates that dividend-focused strategies can still generate strong capital appreciation.

For investors looking to supplement retirement income or build a passive income stream, SCHD offers a reliable and diversified option.

Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.

icon

Bobby Insight

bobby-insight

SCHD is a strong buy for income-focused investors seeking a low-cost, reliable dividend ETF with a track record of payout growth.

The ETF's high yield, low fees, and strong performance make it a compelling long-term holding. Risks include potential dividend cuts in a recession, but the diversified portfolio mitigates this.

What This Means for Me

means-for-me
If you hold SCHD, you can count on a growing income stream while benefiting from capital appreciation. For those holding individual stocks like UNH, MRK, or HD, the ETF provides diversification. Investors seeking passive income should consider SCHD as a core holding.

Read More

Product

Partner

Markets

Stocks

© 2026 Flow AI Limited. All Rights Reserved.

Bobby, the world's first financial AI Agent, is developed by Flow AI, an AI-driven company. Flow AI is dedicated to providing global investors with AI-powered financial services across multiple markets.

Waffo.com Limited (authorised distributor): RM 1903, 19/F Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong.

iconicon

What This Means for Me

If you hold SCHD, you can count on a growing income stream while benefiting from capital appreciation. For those holding individual stocks like UNH, MRK, or HD, the ETF provides diversification. Investors seeking passive income should consider SCHD as a core holding.
Bobby
cs@bobby.ai
Bobby AI
RockFlow Platform
Stock Event
Macro Event
Industry Event
NVDA
AAPL
MSFT
AMZN
GOOG
META
TSLA
Privacy Policy
Terms of Use
iconicon

Stock to Watch

StocksImpactAnalysis
UNH
Positive
As a top holding in SCHD, UNH benefits from the ETF's focus on steady earnings and dividend consistency.
MRK
Positive
As a top holding in SCHD, MRK benefits from the ETF's focus on steady earnings and dividend consistency.
HD
Positive
As a top holding in SCHD, HD benefits from the ETF's focus on steady earnings and dividend consistency.

Tempus AI Rockets 39% on Cancer Vaccine Breakthrough

Bullish Tempus AI's surge is driven by the validation of its pending Personalis acquisition, which could transform its precision medicine business.

PSNLTEMMRKMRNA
Aug 23, 2026

Moderna, Merck mRNA Cancer Vaccine Succeeds: What Now?

Neutral The first successful Phase 3 mRNA cancer vaccine trial is a game-changer for Moderna and Merck, but investors should weigh Moderna's higher risk against Merck's stability.

MRNAMRK
Aug 19, 2026

Berkshire's Big Bet on Housing: Should You Buy XHB?

Neutral Berkshire's acquisition of Taylor Morrison signals confidence in housing, but XHB's long-term underperformance suggests caution for investors.

XHBHDOCBRK.A
Aug 15, 2026